Your session is about to expire
← Back to Search
Epidural Steroids for Back Pain
Phase 3
Recruiting
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients scheduled to undergo 1 to 2 level laminectomy
Between the ages of 18-85
Must not have
Minimally invasive surgery
Non-English speakers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights
Pivotal Trial
Summary
This trial tests if applying a steroid during back surgery helps patients recover faster and need less pain medication. It focuses on patients having a specific type of back surgery and looks at their recovery and pain levels.
Who is the study for?
This trial is for adults aged 18-85 undergoing a specific back surgery called lumbar laminectomy. It's not for those who don't speak English, have had daily opioid use in the last six months, need additional spine procedures, have chronic pain conditions, uncontrolled diabetes (A1C > 6.5), weakened immune systems, prostate issues causing urinary problems or are allergic to Depo-Medrol and steroids.
What is being tested?
The study tests if applying Depo-Medrol steroid directly to the spinal area during surgery can reduce post-surgery opioid use and improve recovery outcomes like hospital stay duration and return-to-work time compared to a placebo (no active medication).
What are the potential side effects?
Potential side effects of Depo-Medrol may include increased blood sugar levels, risk of infection due to immune system suppression, mood swings, weight gain around the face or abdomen, insomnia and potential increase in blood pressure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a surgery to remove part of one or two vertebrae.
Select...
I am between 18 and 85 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I had or will have surgery with small incisions.
Select...
I do not speak English.
Select...
I am undergoing or have undergone a spinal fusion or revision at the same level.
Select...
I have a long-term pain condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Opioid consumption [Both Groups]
Opioid use total [Both Groups]
Secondary study objectives
Medical Complications [Both Groups]
Numeric Rating Pain Scale [Both Groups]
Oswestry Low Back Pain Disability Questionnaire [Both Groups]
+3 moreAwards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group 1: Topical SteroidExperimental Treatment1 Intervention
Group II: Group 2: Topical Normal SalinePlacebo Group1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Intra-operative topical epidural steroids, such as dexamethasone or methylprednisolone, are commonly used to manage postoperative pain by reducing inflammation and pain at the surgical site. These steroids work by inhibiting the release of inflammatory mediators and reducing the activity of immune cells that contribute to inflammation.
This mechanism is crucial for postoperative pain patients as it helps to minimize pain, reduce the need for opioid analgesics, and promote faster recovery. Additionally, other treatments like nonsteroidal anti-inflammatory drugs (NSAIDs) and local anesthetics may be used to provide further pain relief by blocking pain signals and reducing inflammation.
Advances in topical analgesics.
Advances in topical analgesics.
Find a Location
Who is running the clinical trial?
Hospital for Special Surgery, New YorkLead Sponsor
250 Previous Clinical Trials
61,186 Total Patients Enrolled
2 Trials studying Infections
785 Patients Enrolled for Infections
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your diabetes is not well controlled, with an A1C level higher than 6.5.You are allergic to Depo-Medrol, glucocorticoids, or other steroids.I am scheduled for a surgery to remove part of one or two vertebrae.You have used opioid medication daily in the past 6 months.I had or will have surgery with small incisions.I do not speak English.I have a condition that weakens my immune system, like active cancer treatment or a history of transplant.I am undergoing or have undergone a spinal fusion or revision at the same level.I have a long-term pain condition.I am between 18 and 85 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1: Topical Steroid
- Group 2: Group 2: Topical Normal Saline
Awards:
This trial has 1 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger